PageSourceSearch

https://www.curasight.com/about-us/

html curasight.com collected 2026-10-04 19:38:24 UTC 19,735 bytes, 312 lines download raw bytes

1<!DOCTYPE html>
2<html lang="en">
3<head>
4	
5
6<title>About Us - Curasight</title>
7<meta property="og:title" content="About Us - Curasight" />
8<meta name="twitter:title" content="About Us - Curasight" />
9<link rel="canonical" href="https://www.curasight.com/about-us/">
10<meta charset="utf-8" />
11<meta http-equiv="X-UA-Compatible" content="IE=edge" />
12<meta name="viewport" content="width=device-width, initial-scale=1.0" />
13<meta property="og:url" content="https://www.curasight.com/about-us/" />
14<meta name="twitter:url" content="https://www.curasight.com/about-us/" />
15<meta property="og:type" content="website"/>
16
17<meta name="Description" content="" />
18<meta property="og:description" content="" />
19<meta name="twitter:description" content="" />
20<meta name="twitter:card" content="summary">
21
22
23<style id="_cssgrid">#_44-2{grid-area:1/1/21/25;}@media(max-width: 768px) {._section-container[data-id^="44-"] ._grid { display: block; }}
24#_12-14{grid-area:1/1/48/25;}@media(max-width: 768px) {._section-container[data-id^="12-"] ._grid { display: block; }}
25#_11-1{grid-area:15/1/41/17;}#_11-3{grid-area:1/1/12/25;}#_11-4{grid-area:1/17/38/25;}#_11-5{grid-area:1/1/15/13;}@media(max-width: 768px){#_11-1{grid-area:14/1/24/13;}#_11-3{grid-area:1/1/12/25;}#_11-4{grid-area:1/13/29/25;}#_11-5{grid-area:1/1/14/13;}}@media(max-width: 667px){#_11-1{grid-area:14/1/24/25;}#_11-3{grid-area:1/1/6/25;}#_11-4{grid-area:24/1/52/25;}#_11-5{grid-area:1/1/14/25;}}
26</style>
27<style id="_iegrid">#_44-2{-ms-grid-row:1;-ms-grid-column:1;-ms-grid-row-span:20;-ms-grid-column-span:24;}#_12-14{-ms-grid-row:1;-ms-grid-column:1;-ms-grid-row-span:47;-ms-grid-column-span:24;}#_11-1{-ms-grid-row:15;-ms-grid-column:1;-ms-grid-row-span:26;-ms-grid-column-span:16;}#_11-3{-ms-grid-row:1;-ms-grid-column:1;-ms-grid-row-span:11;-ms-grid-column-span:24;}#_11-4{-ms-grid-row:1;-ms-grid-column:17;-ms-grid-row-span:37;-ms-grid-column-span:8;}#_11-5{-ms-grid-row:1;-ms-grid-column:1;-ms-grid-row-span:14;-ms-grid-column-span:12;}@media(max-width: 768px){#_11-1{-ms-grid-row:14;-ms-grid-column:1;-ms-grid-row-span:10;-ms-grid-column-span:12;}#_11-3{-ms-grid-row:1;-ms-grid-column:1;-ms-grid-row-span:11;-ms-grid-column-span:24;}#_11-4{-ms-grid-row:1;-ms-grid-column:13;-ms-grid-row-span:28;-ms-grid-column-span:12;}#_11-5{-ms-grid-row:1;-ms-grid-column:1;-ms-grid-row-span:13;-ms-grid-column-span:12;}}@media(max-width: 667px){#_11-1{-ms-grid-row:14;-ms-grid-column:1;-ms-grid-row-span:10;-ms-grid-column-span:24;}#_11-3{-ms-grid-row:1;-ms-grid-column:1;-ms-grid-row-span:5;-ms-grid-column-span:24;}#_11-4{-ms-grid-row:24;-ms-grid-column:1;-ms-grid-row-span:28;-ms-grid-column-span:24;}#_11-5{-ms-grid-row:1;-ms-grid-column:1;-ms-grid-row-span:13;-ms-grid-column-span:24;}}</style>
28
29
30<link rel="stylesheet" href="/main.css?1774614085395" type="text/css">
31
32
33
34<link rel="apple-touch-icon" sizes="180x180" href="/favicons/apple-touch-icon.png">
35<link rel="icon" type="image/png" sizes="32x32" href="/favicons/favicon-32x32.png">
36<link rel="icon" type="image/png" sizes="16x16" href="/favicons/favicon-16x16.png">
37<link rel="manifest" href="/favicons/site.webmanifest">
38<link rel="mask-icon" href="/favicons/safari-pinned-tab.svg" color="#446084">
39<link rel="shortcut icon" href="/favicons/favicon.ico">
40<meta name="msapplication-TileColor" content="#ffffff">
41<meta name="msapplication-config" content="/favicons/browserconfig.xml">
42<meta name="theme-color" content="#ffffff">
43
44
45
46
47
48
49
50
51
52</head>
53<body class="no-js live page12 sticky-all subnav-type-hover subnav-width-auto nav-thirdlevel-hidden nav-swipe-right nav-toggle-right">
54    <div id="top"></div>
55    <svg style="display: none;">
56    <symbol id="svg-Close" viewBox="0 0 44 44"><path d="M38.824 0L44 5.178 5.176 44 0 38.825 38.824 0z" fill="currentColor"></path><path d="M5.176 0L44 38.825 38.824 44 0 5.178 5.176 0z"  fill="currentColor"></path></symbol><symbol id="svg-Nav-hide" viewBox="0 0 26 26"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 1024 1024"><path fill="currentColor" d="M0 789q0 5 2 10t5 8q8 8 18.5 8t18.5-8l442-442 443 442q8 8 18.5 8t17.5-8q8-7 8-17.5t-8-18.5L504 310q-7-7-17.5-7t-18.5 7L7 771q-3 4-5 8.5T0 789z"/></svg></symbol>
56<symbol id="svg-Nav-show" viewBox="0 0 26 26"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 1024 1024"><path fill="currentColor" d="M0 329q0-5 2-10t5-9q8-7 18.5-7t18.5 7l442 443 443-443q8-7 18.5-7t17.5 7q8 8 8 18.5t-8 18.5L504 807q-7 8-17.5 8t-18.5-8L7 347q-3-4-5-9t-2-10v1z"/></svg></symbol><symbol id="svg-LinkedIn" viewBox="0 0 1792 1792"><path d="M477 625v991H147V625h330zm21-306q1 73-50.5 122T312 490h-2q-82 0-132-49t-50-122q0-74 51.5-122.5T314 148t133 48.5T498 319zm1166 729v568h-329v-530q0-105-40.5-164.5T1168 862q-63 0-105.5 34.5T999 982q-11 30-11 81v553H659q2-399 2-647t-1-296l-1-48h329v144h-2q20-32 41-56t56.5-52 87-43.5T1285 602q171 0 275 113.5t104 332.5z" fill="currentColor"></path></symbol><symbol id="svg-YouTube-play" viewBox="0 0 147 147"><path d="M73.5 147C32.907 147 0 114.093 0 73.5S32.907 0 73.5 0 147 32.907 147 73.5 114.093 147 73.5 147zm29.01-73.29L55.59 50.327a2 2 0 0 0-2.892 1.79v46.767a2 2 0 0 0 2.892 1.79l46.92-23.384a2 2 0 0 0 0-3.58z" fill="currentColor" fill-rule="evenodd"></path></symbol><symbol id="svg-Search" viewBox="0 0 1792 1792"><path fill="currentColor" d="M1216 832q0-185-131.5-316.5t-316.5-131.5-316.5 131.5-131.5 316.5 131.5 316.5 316.5 131.5 316.5-131.5 131.5-316.5zm512 832q0 52-38 90t-90 38q-54 0-90-38l-343-342q-179 124-399 124-143 0-273.5-55.5t-225-150-150-225-55.5-273.5 55.5-273.5 150-225 225-150 273.5-55.5 273.5 55.5 225 150 150 225 55.5 273.5q0 220-124 399l343 343q37 37 37 90z"/></symbol><symbol id="svg-E-mail" viewBox="0 0 1792 1792"><path d="M1792 710v794q0 66-47 113t-113 47H160q-66 0-113-47T0 1504V710q44 49 101 87 362 246 497 345 57 42 92.5 65.5t94.5 48 110 24.5h2q51 0 110-24.5t94.5-48 92.5-65.5q170-123 498-345 57-39 100-87zm0-294q0 79-49 151t-122 123q-376 261-468 325-10 7-42.5 30.5t-54 38-52 32.5-57.5 27-50 9h-2q-23 0-50-9t-57.5-27-52-32.5-54-38T639 1015q-91-64-262-182.5T172 690q-62-42-117-115.5T0 438q0-78 41.5-130T160 256h1472q65 0 112.5 47t47.5 113z" fill="currentColor"></path></symbol>    
57</svg>
58
59
60
61
62<a class="_skiplink" id="_skiptocontent" href="#_main" accesskey="s"><span>Skip to main content</span></a><a class="_skiplink" id="_skiptonav" href="#_mainnav"><span>Skip to navigation</span></a><a class="_skiplink" id="_skiptosearch" href="#"><span>Skip to search</span></a>
63
64<header>
65    <div id="_mobile-header"><a class="_logotype" href="/"><img src="/files/images/curasight-site-logo.png" alt="Curasight"></a><button role="button" id="_toggle-nav" aria-expanded="false" aria-controls="_mobile-menu">
66        <span>
67            <span class="show">Menu</span>
68            <span class="hide">Close</span>
69        </span>
70    </button></div>
71    <div id="_mobile-menu" class="_mobile-menu">
72        <div class="_mobile-menu-row _row-0">
73    <div class="_searchform desktop-lightbox mob-regular">
74       <form action="/search/">
75            <input aria-label="Search" class="_searchbox" placeholder="Search" name="q" value="" autocomplete="off" /><button aria-label="Submit search"><svg role="img" width="1792" height="1792" viewBox="0 0 1792 1792">
76        <use xlink:href="#svg-Search"></use>
77    </svg></button>
78            <div class="_instantsearch" data-nohits="No results found"></div>
79        </form>
80        
81        <button class="_toggleSearch" aria-hidden="true"><svg role="img" width="1792" height="1792" viewBox="0 0 1792 1792">
82        <use xlink:href="#svg-Search"></use>
83    </svg></button>
84        
85    </div>
86</div>
87        <div id="_desktop-header"><div class="_cell-0-0"></div><div class="_cell-0-1"><a href="/investor/the-share/" id="_ticker"><div class="ticker">
88    <div class="_ticker-text">
89        <strong><span class="_ticker-price">&nbsp;</span> DKK</strong>
90        <span class="_ticker-changePerc">&nbsp;</span>%
91        | <span data-tickerformat="D MMM, YYYY" data-when="QuoteTime"></span>
92    </div>
93</div>
94</a><!-- --></div><div class="_cell-0-2"></div><div class="_cell-1-0"></div><div class="_cell-1-1"><a class="_logotype" href="/"><img src="/files/images/curasight-site-logo.png" alt="Curasight"></a><nav id="_mainnav" aria-label="Main navigation">
95<ul id="_menu1" class="level1" data-togglelabel="Toggle navigation"><li class="expanded selected"><a  href="/about-us/">About Us</a><ul id="_menu12" class="level2" aria-hidden="true"><li><a  href="/about-us/our-motivation/">Our Motivation</a></li><li><a  href="/about-us/management-team/">Management Team</a></li><li><a  href="/about-us/board-of-directors/">Board of Directors</a></li><li><a  href="/about-us/history/">History</a></li></ul></li><li><a  href="/upar-the-target/">uPAR – the Target</a><ul id="_menu16" class="level2" aria-hidden="true"><li><a  href="/upar-the-target/upar-theranostics/">uPAR Theranostics</a></li><li><a  href="/upar-the-target/utrace/">uTRACE®</a></li><li><a  href="/upar-the-target/utreat/">uTREAT®</a></li><li><a  href="/upar-the-target/disease-areas/">Disease Areas</a></li><li><a  href="/upar-the-target/publications/">Publications</a></li></ul></li><li><a  href="/pipeline/">Pipeline</a></li><li><a  href="/news/">News and Media</a><ul id="_menu27" class="level2" aria-hidden="true"><li><a  href="/news/press-releases/">Press releases</a></li><li><a  href="/news/presentations/">Presentations</a></li><li><a  href="/news/subscribe/">Subscribe</a></li><li><a  href="/news/frequently-asked-questions/">FAQ</a></li></ul></li><li><a  href="/investor/">Investor</a><ul id="_menu22" class="level2" aria-hidden="true"><li><a  href="/investor/curasight-as-an-investment/">Curasight as an investment</a></li><li><a  href="/investor/reports/">Financial reports</a></li><li><a  href="/investor/the-share/">The Share</a></li><li><a  href="/investor/general-meetings/">General meetings</a></li><li><a  href="/investor/calendar/">Calendar</a></li><li><a  href="/investor/events/">Events</a></li><li><a  href="/investor/corporate-governance/">Corporate Governance</a></li><li><a  href="/investor/analyst-coverage/">Analysts</a></li><li><a  href="/investor/archive-financing/">Archive financing</a></li></ul></li><li><a  href="/contact/">Contact</a></li></ul></nav>
96    <div class="_searchform desktop-lightbox mob-regular">
97       <form action="/search/">
98            <input aria-label="Search" class="_searchbox" placeholder="Search" name="q" value="" autocomplete="off" /><button aria-label="Submit search"><svg role="img" width="1792" height="1792" viewBox="0 0 1792 1792">
99        <use xlink:href="#svg-Search"></use>
100    </svg></button>
101            <div class="_instantsearch" data-nohits="No results found"></div>
102        </form>
103        
104        <button class="_toggleSearch" aria-hidden="true"><svg role="img" width="1792" height="1792" viewBox="0 0 1792 1792">
105        <use xlink:href="#svg-Search"></use>
106    </svg></button>
107        
108    </div>
109</div><div class="_cell-1-2"></div></div>
110        
111    </div>
112</header>
113    
114<nav class="breadcrumb" aria-label="Breadcrumb"><ul><li><a href="/">Home</a></li><li><p>About Us</p></li></ul></nav>
115
116    <div id="_middleregion"><div id="_leftregion">
117		<div data-id="44-1" class="_section-container">
118			
119			<div class="_section">
120				<div class="_grid">
121					
122            <div id="_44-2" class="_block">
123                
124        
125        <div class="_block-content">
126            
127<nav id="subnav" aria-label="Section">
128<h2><a href="/about-us/">About Us</a></h2><ul><li><a href="/about-us/our-motivation/">Our Motivation</a></li><li><a href="/about-us/management-team/">Management Team</a></li><li><a href="/about-us/board-of-directors/">Board of Directors</a></li><li><a href="/about-us/history/">History</a></li></ul>
129</nav>
130        </div>
131        
132    
133            </div>
134        
135				</div>
136			</div>
137			
138		</div>
139	</div><main id="_main">
140		<div data-id="12-1" class="_section-container">
141			
142			<div class="_section">
143				<div class="_grid">
144					
145            <div id="_12-14" class="_block">
146                
147        
148        <div class="_block-content">
149            <h1>About Curasight</h1>
150<p><strong>First-in-Class Radioligand Therapy Targeting uPAR – the Driver of Cancer Aggressiveness</strong></p>
151<p>Curasight is a clinical-stage radiopharmaceutical company developing uTREAT<sup>®</sup>, a first-in-class uPAR-targeted radioligand therapy (RLT) designed to treat aggressive solid tumors across multiple indications.</p>
152<p>uPAR (urokinase-type plasminogen activator receptor) is broadly expressed in aggressive cancers and is associated with invasion, angiogenesis, and metastasis, enabling a platform-based development strategy built on a shared biological target and shared uPAR-targeting ligand. One target. One therapy. A pipeline-in-a-drug across aggressive solid tumors.</p>
153<p>Curasight’s therapeutic platform, uTREAT<sup>®</sup>, is supported by uTRACE<sup>®</sup>, our clinically validated uPAR PET diagnostic platform built on the same uPAR-targeting ligand. uTRACE<sup>®</sup> enables a true theranostic approach by supporting patient selection, confirming tumor targeting, and de-risking therapeutic development through human imaging validation. uTRACE<sup>®</sup> is fully developed, GMP-manufactured, and has been evaluated in nine clinical trials involving 450 patients across eight different solid tumor types. This extensive clinical experience provides direct human validation of uPAR as a therapeutic target and demonstrates robust tumor uptake and favorable biodistribution — forming the foundation for uTREAT<sup>®</sup>.</p>
154<p>The platform is built on more than a decade of rigorous translational research conducted at Copenhagen University Hospital and the University of Copenhagen, providing a strong academic and clinical foundation for Curasight’s first-in-class uPAR targeting approach.</p>
155<p>Together, this combination of validated biology, the right radioligand modality, and human clinical proof-of-concept positions uTREAT<sup>®</sup> as a next-generation radioligand therapy platform.</p>
156        </div>
157        
158    
159            </div>
160        
161				</div>
162			</div>
163			
164		</div>
165	</main></div><footer>
166		<div data-id="11-1" class="_section-container background-mediumgrey space">
167			
168			<div class="_section">
169				<div class="_grid">
170					
171            <div id="_11-5" class="_block">
172                
173        
174        <div class="_block-content">
175            
176<img src="/files/images/curasight-site-logo.png" alt="Curasight" class="footer-logo" />
177
178        </div>
179        
180    
181            </div>
182        
183            <div id="_11-4" class="_block">
184                
185        
186        <div class="_block-content">
187            <h2>Subscribe</h2><p>Subscribe to get the latest news first.</p>
188
189<form action="//publish.ne.cision.com/Subscription/Subscribe" method="post" class="_subscribe">
190    <input type="hidden" name="subscriptionUniqueIdentifier" value="3094420cd5"/>
191    <input type="hidden" name="Replylanguage" value="en"/> 
192    <div class="_fields">
193        <div id="973969405774965"></div>
194        <input style="display: none;" name="Language" type="checkbox" checked value="en">
195        <h3>Choose type</h3>
196        <div class="types">
197            
198            <label><input name="informationtype" type="checkbox" value="kmk,rpt,rdv"><span>Financial reports</span></label>
199            
200            <label><input name="informationtype" type="checkbox" value="prm"><span>Press releases</span></label>
201            
202        </div>
203        <label>
204            <span>E-mail</span>
205            <input required type="email" name="Email" placeholder="E-mail">
206            <div class="_result _fail">Something went wrong - please make sure you entered the correct email.</div>
207        </label>
208        
209        <div class="_privacynotice"><p><em data-renderer-mark="true">I consent to Curasight handling my personal data. See Curasight's&nbsp;<a data-testid="link-with-safety" href="/terms-of-use/" title="/terms-of-use/" data-renderer-mark="true" class="css-1rn59kg">Terms of Use</a> for information about how we handle personal data.</em></p></div><button><span>Subscribe</span></button>
210    </div>
211    <div class="_result _success">Thank you. You will get an e-mail message to activate your subscription.</div>
212</form>
213
214
215        </div>
216        
217    
218            </div>
219        
220            <div id="_11-1" class="_block">
221                
222        
223        <div class="_block-content">
224            <p>Curasight is a clinical-stage radiopharmaceutical company advancing uTREAT<sup>®</sup>, a first-in-class uPAR-targeted radioligand therapy (RLT) designed to treat aggressive solid tumors across multiple indications. uTREAT<sup>®</sup> is supported by the clinically validated imaging agent uTRACE<sup>®</sup>, built on the same uPAR-targeting ligand, enabling a differentiated and de-risked theranostic approach.</p>
225<p>uPAR (urokinase-type plasminogen activator receptor) is broadly expressed in aggressive cancers and plays a central role in tumor invasion, angiogenesis, and metastasis. By focusing on this validated and widely expressed target, Curasight is pursuing a therapeutic strategy across multiple high-unmet-need solid tumors using a shared biological target and targeting ligand.</p>
226<p><strong>One target. One therapy. A pipeline-in-a-drug across aggressive solid tumors.</strong></p>
227        </div>
228        
229    
230            </div>
231        
232				</div>
233			</div>
234			
235		</div>
236	
237		<div data-id="11-2" class="_section-container background-darkgrey">
238			
239			<div class="_section">
240				<div class="_grid">
241					
242            <div id="_11-3" class="_block">
243                
244        
245        <div class="_block-content">
246            
247
248<div class="footer--bottom">
249
250    <a href="#top" class="back-to-top">
251        <svg role="img" aria-label="Back to top" width="16" viewB
251ox="0 0 26 26"><use xlink:href="#svg-Nav-hide"></use></svg>
252    </a>
253    
254    <ul class="footer__nav"><li><a href="/news/">News and Media</a></li><li><a href="/contact/">Contact</a></li><li><a href="/terms-of-use/">Terms of use</a></li></ul>
255    
256    
257    <p class="footer__copyright">Copyright 2026 &copy; <strong>Curasight</strong></p>
258    
259</div>
260    
261
262
263    
264
265    
266    
267
268
269        </div>
270        
271    
272            </div>
273        
274				</div>
275			</div>
276			
277		</div>
278	</footer>
279    
280<div id="_cookiebanner-opt-in-out" class="hidden _cookiebanner-opt-in-out" data-nosnippet="true">
281    <div class="_cookiebanner-opt-in-out--inner">
282        <p>This website uses cookies to provide the best possible user experience. If you continue without making any changes you allow this.
283<a href="/terms-of-use/">Read more about cookies here</a></p>
284        <div class="_cookie-buttons">
285            <button><span>Accept</span></button> 
286        </div>
287
288        
289
290    </div>
291    
292</div>
293
294    
295
296
297<script nonce="7IT9y9q0npWrl1QbptfM5w==">window.waasconfig = {"lang":"en","pageId":12,"template":1,"gaoptout":true,"consentFunctions":[],"initFunctions":[],"cleanupFunctions":[],"optout":true,"plausible":"curasight.com","thousandDelimiter":"","decimalSign":"","youtubedisclaimer":"","youtubeaccept":"","vimeodisclaimer":"","vimeoaccept":"","mapsdisclaimer":"","mapsaccept":""};</script>
297<script src="/main.js?1774614054815"></script>
297
298
299
300    
300<script defer src="/api/analytics/"></script>
300
301
302		<div class="overlay-cover"></div>
303    <div class="overlay" aria-hidden="true">
304        <div class="overlay__outer">
305            <div class="overlay__inner">
306                <button class="overlay__close">Close</button>
307                <div class="overlay__content"></div>
308            </div>
309        </div>
310    </div>
311</body>
312</html>

Line numbers count LF bytes from the start of the resource, as the search results do. Vendor segments are library code the classifier recognised; they are stored but not indexed. Bytes are shown as Latin1 characters, one per byte.